A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
This trial is active, not recruiting.
|Conditions||total shoulder arthroplasty, glenohumeral osteoarthritis|
|Sponsor||Western Orthopaedics Research and Education Foundation|
|Start date||November 2012|
|End date||February 2013|
|Trial size||150 participants|
|Trial identifier||NCT01726972, 369439-1|
The proposed study aims to objectively assess 2-year clinical and radiographic results for the rate of glenoid component loosening in total shoulder arthroplasty (TSA). This retrospective radiographic review will provide evidence for equivalence or superiority in curtailing loosening, a known complication in arthroplasty, when a hemostatic agent is utilized in conjunction with cement at the glenoid.
time frame: 2 years
Male or female participants from 21 years up to 90 years old.
- Patients must have completed at least 2 years follow-up following their total shoulder replacement
- Patients must have had radiographic imaging obtained at that 2 years
- Patients less than 21 years of age
- Patients who have been imprisoned since the time of surgery
- Patients who are mentally impaired
|Official title||A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty|
Call for more information